Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-12,935
Closed -$904K – 486
2024
Q4
$904K Buy
+12,935
New +$1.07M 0.1% 208
2024
Q2
– Sell
-10,802
Closed -$1.2M – 351
2024
Q1
$1.2M Sell
10,802
-4,565
-30% -$544K 0.1% 219
2023
Q4
$1.99M Buy
15,367
+10,225
+199% +$1.41M 0.17% 161
2023
Q3
$838K Buy
+5,142
New +$904K 0.07% 268
2023
Q2
– Sell
-10,417
Closed -$1.39M – 330
2023
Q1
$1.39M Buy
+10,417
New +$1.22M 0.14% 206

Other funds holding ACLS

FORA Capital's ACLS Position: Q1 2025 in Review

FORA Capital sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 12,935 shares — an estimated $904K sold.

FORA Capital first reported a position in ACLS in Q1 2023 and held it in 5 quarters. The position peaked at $1.99M in Q4 2023. 307 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • FORA Capital reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • FORA Capital sold 12,935 Axcelis shares in Q1 2025, an estimated $904K.
  • FORA Capital first reported a position in Axcelis in Q1 2023 and held it in 5 quarters.
  • FORA Capital's Axcelis position peaked at $1.99M in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on FORA Capital's 13F filing for Q1 2025, filed 14 May 2025.